Abstract
Tissue formed by the cells of the mesoderm is known as mesenchyme and it is from the mesenchyme that the connective tissue of the body develops. Quantitatively some 80% of connective tissue is found in the dermis of the skin and in the bone with the amount of collagen being shared almost equally between them.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Albright F, Smith PH, Richardson AM. Postmenopausal osteoporosis - its clinical features. JAMA 1941;116:2465–2474.
Alberts B, Bray D, Lewis T et al. Cell-cell adhesion and the extracellular matrix. In: Alberts B, editor. Molecular biology of the cell. New York: Garland Publishing, 1983;673–715.
McConkey B, Fraser GM, Bligh AS, Whitely H. Transparent skin and osteoporosis. Lancet 1963;i:693–95.
Lindsay R. Pathogenesis, detection and prevention of postmenopausal osteoporosis. In: Studd JWW, Whitehead MI, editors. The menopause. Oxford: Blackwell Scientific Publications, 1988;156–67.
Smith R. Collagen and disorders of bone. Editorial review. Clin Sci 1980;59:215–23.
Forbes RM, Cooper AR, Mitchell L. The composition of the adult human body as determined by chemical analysis. J Biol Chem 1953;203:359–66.
Hall DA. Chemical and biochemical changes in ageing connective tissues. In: Hall DA, editor. The ageing of connective tissues. New York: Academic Press, 1976;79–144.
Gallagher JC, Nordin BEC. Oestrogens and calcium metabolism. Front Horm Res 1983;2:98–117.
Robins SP, Duncan A, Reid DM, Peterson CR. Urinary hydroxpyridium crosslinks of collagen as markers of resorption in a range of metabolic bone diseases. Program and abstracts. Tenth International Conference on Calcium Regulating Hormones/Eleventh Annual Meeting of the American Society for Bone and Mineral Research. Joint Meeting, Montreal. J Bone Min Res 1989;4:1120.
Birkenhager-Frenkel DH. Assessment of porosity in bone specimens, differences in chemical composition between normal bone and bone from patients with senile osteoporosis. In: Gaillard PJ, editor. Fourth European Symposium on Calcified Tissues. Amsterdam: Excerpta Medica, 1966;8–9.
Brincat A, Moniz CJ, Studd JWW, Darby AJ, Magos A, Cooper D. Sex hormones and skin collagen content in postmenopausal women. Br Med J 1983;287:1337–1338.
Brincat M, Moniz CJ, Studd JWW, Darby AJ, Magos A, Emburey G, Versi E. Long term effects of the menopause and sex hormones on skin thickness. Br J Obstet Gynaecol 1985;92:256–59.
Brincat M, Moniz CF, Kabalan S et al. Decline in skin collagen content and metacarpal index after the menopause and its prevention with sex hormone replacement. Br J Obstet Gynaecol 1987;94:126–29.
Brincat M, Wong Ten Yuen A, Studd JWW, Montgomery J, Magos A, Savvas M. Response of skin thickness and metacarpal index to oestradiol therapy in postmenopausal women. Obstet Gynaecol 1987;70:538–41.
Brincat M, Versi E, Moniz CF, O’Dowd T, Magos A, Kabalan S, Studd JWW. Skin collagen changes in postmenopausal women receiving different regimens of estrogen therapy. Obstet Gynaecol 1987;70:123–27.
Brincat M, Versi E, Moniz CF, O’Dowd T, Magos A, Kabalan S, Studd JWW. Skin collagen changes in postmenopausal women treated with oestradiol gel. Maturitas 1987;9:1–5.
Black NM, Shuster S, Bottoms E. Osteoporosis, skin collagen and androgen. Br Med J 1970;4:773–74.
Kaplan JA. Identifications of estrogen receptors on osteoblast. International Conference on Osteoporosis, Aalbourg. 1987, unpublished abstract.
Vashinav R, Gallagher JA, Beresford NN, Russell RGG. Proliferative effects of estrogens on bone-derived cells. Valcif Tiss Int 1984;36:559.
Brincat M, Studd JWW. Skin and the menopause. In: Studd JWW, Whitehall MI, editors. The menopause. Oxford: Blackwell Scientific Publications, 1988;85–101.
McConkey B, Fraser GM, Bligh AS. Transparent skin and osteoporosis. A study in patients with rheumatoid disease. Ann Rheum Dis 1965;25:219–23.
Smith P. Age change in the female urethra. Br J Urol 1972;44:667–76.
Versi E, Cardozo LD. Urethral vascular pulsations. Proceedings of the International Continence Society, London. 1985;503–94.
Versi E, Cardozo LD, Brincat M, Cooper D, Montgomery JC, Studd JWW. Correlation of urethral physiology and skin collagen in postmenopausal women. Br J Obstet Gynaecol 1988;95:147–52.
Versi E, Cardozo LD, Studd JWW, Brincat M, O’Dowd TM, Cooper D. Internal urinary sphincter in maintenance of female continence. Br Med J 1986;292:166–67.
Josif CS, Batia S, Ed A, Astedt B. Estrogen receptors in the human female lower urinary tract. Am J Obstet Gynaecol 1981;141:817–20.
Faber P, Heindenreich J. Treatment of stress incontinence with estrogen in postmenopausal women. Urol Int 1977;32:221–23.
Walter S, Wolf I, Barlebo H, Hensen HK. Urinary incontinence in postmenopausal women treated with estrogens. A double blind clinical trial. Urol Int 1978;33:136–43.
Hilton P, Stanton SL. The use of intravaginal oestrogen cream in genuine stress incontinence. Br J Obstet Gynaecol 1983; 90:940–44.
Lobo R. Prevention of postmenopausal osteoporosis. In: Mishel DR, editor. Menopause, physiology and pharmacology. Chicago: Year Book Medical Publishers 1986;165–86.
Haussler MR, Donaldson CA, Allegretto EA, Marion D, Mangelsdorf J, Kelly MA, Pike JW. New actions of 1.25 dihydroxyvitamin D3, possible clues to the pathogenesis of postmenopausal osteoporosis. In: Christiansen C, editor. Osteoporosis. Proceedings of the Copenhagen International Symposium on Osteoporosis, Copenhagen, Glostrup Hospital, 1984:725–36.
Grosman N, Hudberg E, Schon J. The effects of estrogenic treatment of the acid mucopoly saccharide pattern in skin of mice. Acta Pharmacol Toxicol 1971;30:458–64.
Uzuka M, Nakamuza K, Ohta S, Mori Y. The mechanism of estrogen-induced increase in hyaluronic acid biosynthesis with special reference to estrogen receptors in the mouse skin. Biochem Biophys Acta 1980;627:199–206.
Savvas M, Studd JWW, Fogelam I, Dooley M, Montgomery J, Murby B. Skeletal effects of oral estrogen compared with subcutaneous estrogen and testosterone in postmenopausal women. Br Med J 1988;297:331–33.
Studd JWW, Cardozo LD, Gibb DMF, Tuck SM, Magos AL, Brincat M, Dooper DI. Hormone implants in women following hysterectomy and bilateral salpingo-oophorectomy. In: Van Herendael H, editor. The climacteric - An update. The Hague: MTP, 1984;149–55.
Studd JWW, Thom MH, Paterson NEL, Wade Evans T. The prevention and treatment of endometrial pathology in postmenopausal women receiving exogenous estrogens. In: Passeto N, Paoletti R, Ambruc CJ, editors. The menopause and postmenopausal. Lancaster: MTP, 1980:127–39.
Studd JWW, Thom M. Estrogens and endometrial cancer. In: Studd JWW, editor. Progress is obstetrics and gynecology. London: Churchill Livingstone, 1981;182–98.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Brincat, M., Baron, Y.M., Galea, R., Buhagiar, A. (1994). Estrogen Deficiency and Connective Tissues. In: Crosignani, P.G., Paoletti, R., Sarrel, P.M., Wenger, N.K., Meschia, M., Soma, M. (eds) Women’s Health in Menopause. Medical Science Symposia Series, vol 7. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-1024-2_27
Download citation
DOI: https://doi.org/10.1007/978-94-011-1024-2_27
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-4446-2
Online ISBN: 978-94-011-1024-2
eBook Packages: Springer Book Archive